Journal article
Sex-based and age-based differences in participation in an in-hospital atrial fibrillation screening study: a prospective cohort study in Switzerland
- Abstract:
- Objectives: The under-representation of women in cardiovascular clinical trials is well documented but cannot be fully explained by sex-specific differences in disease prevalence. We investigated sex-related and age-related disparities in study participation within an atrial fibrillation (AF) screening study conducted among hospitalised patients. Design: Prospective cohort study. Setting: In-hospital patients in a single tertiary care centre in Bern, Switzerland. Participants: Patients aged 65–84 years evaluated for inclusion in the The SilenT AtRial FIBrillation cohort study, with inclusion stratified by sex and age. Interventions: Screening for AF using three consecutive 7-day Holter ECG recordings. Primary and secondary outcome measures: Prevalence of clinical and non-clinical exclusion criteria and participation rates among eligible patients, stratified by sex and age. Results: Of 11 470 patients evaluated, 10 675 were not enrolled. Clinical exclusion criteria were more prevalent among men than women (60.2% vs 50.5%, p<0.001), with prevalence increasing with age in both sexes. Consequently, fewer men met eligibility criteria compared with women (24.3% vs 32.6%, p<0.001). Among eligible patients, women were less likely to participate than men (20.2% vs 30.0%, p<0.001), and participation declined with advancing age in both sexes. Eligible men aged <75 years demonstrated the highest participation rate (34%). Conclusions: Significant sex-dependent and age-dependent disparities exist in both the prevalence of clinical exclusion criteria and participation rates among eligible patients in an AF screening study. These differences should be carefully considered in the design and planning of future clinical studies to improve representativeness.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 700.7KB, Terms of use)
-
- Publisher copy:
- 10.1136/bmjopen-2025-112434
Authors
+ Swiss National Science Foundation
More from this funder
- Funder identifier:
- https://ror.org/00yjd3n13
- Grant:
- 32003B_156292
- Publisher:
- BMJ Publishing Group
- Journal:
- BMJ Open More from this journal
- Volume:
- 16
- Issue:
- 3
- Pages:
- e112434
- Article number:
- bmjopen-2025-112434
- Publication date:
- 2026-03-30
- Acceptance date:
- 2026-03-20
- DOI:
- EISSN:
-
2044-6055
- ISSN:
-
2044-6055
- Language:
-
English
- Keywords:
- Pubs id:
-
2401039
- Local pid:
-
pubs:2401039
- Source identifiers:
-
3903155
- Deposit date:
-
2026-03-31
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record